Delivering more for our investors.
Welcome to our Investor Centre. Here you’ll find information about our business, from presentation and analyst reports, ASX announcements, stock information distribution and tax.
- Loading stock data...
Offices: Melbourne (Australia)
ASX: AVE (previously traded as Phosphagenics, POH)
TPM® products commercialised under license;
- Voveran® TPM Gel; Novartis, India
- Instanac® TPM Gel; Themis Medicare
- Vital ET® Biofunctional Ingredient; Ashland
- TPM® (for personal care only); Ashland
|POH 2018 Half Year Financial Report||956 KB|
|Anti-Bribery & Corruption Policy||195 KB|
|Securities Trading Policy||164 KB|
|Remuneration and Nomination Committee Charter||206 KB|
|Audit & Risk Committee Charter||163 KB|
|Shareholder Communication Policy||151 KB|
|Diversity Policy||156 KB|
|Continuous Disclosure Policy||187 KB|
|Code of Conduct||179 KB|
|Board Charter||211 KB|
|Whistleblower Policy||266 KB|
|Appendix 4G and Corporate Governance Statement||423 KB|